Identification of mutations in TgMAPK1 of Toxoplasma gondii conferring resistance to 1NM-PP1

International Journal for Parasitology: Drugs and Drug Resistance

Volumn 3, Issue , 2013, Pages 93-101

  Sugi, Tatsuki ^a   Kobayashi, Kyousuke ^b   Takemae, Hitoshi ^a   Gong, Haiyan ^a   Ishiwa, Akiko ^a   Murakoshi, Fumi ^a   Recuenco, Frances C ^a   Iwanaga, Tatsuya ^a   Horimoto, Taisuke ^a   Akashi, Hiroomi ^a   Kato, Kentaro ^a,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

Author keywords

1NM PP1; Bumped kinase inhibitor; Drug resistance; TgMAPK1; Toxoplasma gondii

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; AMINO ACID; BUMPED KINASE INHIBITOR; CALCIUM; MITOGEN ACTIVATED PROTEIN KINASE 1; NUCLEOTIDE; PHOSPHOTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL DIVISION; CELL INVASION; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; DRUG RESISTANCE; GENE MUTATION; GENE SEQUENCE; GROWTH INHIBITION; HOST CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; TACHYZOITE; TOXOPLASMA GONDII;

EID: 84880383893     PISSN: 22113207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpddr.2013.04.001     Document Type: Article

References (26)

1. Arnold K., Bordoli L., Kopp J., Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006, 22:195-201.
2. Arrizabalaga G., Ruiz F., Moreno S., Boothroyd J.C. Ionophore-resistant mutant of Toxoplasma gondii reveals involvement of a sodium/hydrogen exchanger in calcium regulation. J. Cell Biol. 2004, 165:653-662.
3. Brmlik M.J., Pandeswara S., Ludwig S.M., Murthy K., Curiel T.J. Parasite mitogen-activated protein kinases as drug discovery targets to treat human protozoan pathogens. J. Signal. Transduct. 2011, 2011:971968.
4. Eaton M., Weiss L., Kim K. Cyclic nucleotide kinases and tachyzoite-bradyzoite transition in Toxoplasma gondii. Int. J. Parasitol. 2006, 36:107-114.
5. Farrell A., Thirugnanam S., Lorestani A., Dvorin J.D., Eidell K.P., Ferguson D.J., Anderson-White B.R., Duraisingh M.T., Marth G.T., Gubbels M.J. A DOC2 protein identified by mutational profiling is essential for apicomplexan parasite exocytosis. Science 2012, 335:218-221.
6. Gubbels M.J., Lehmann M., Muthalagi M., Jerome M.E., Brooks C.F., Szatanek T., Flynn J., Parrot B., Radke J., Striepen B., White M.W. Forward genetic analysis of the apicomplexan cell division cycle in Toxoplasma gondii. PLoS Pathog. 2008, 4:e36.
7. Hanks S.K., Hunter T. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 1995, 9:576-596.
8. Khan F., Tang J.Z., Qin C.L., Kim K. Cyclin-dependent kinase TPK2 is a critical cell cycle regulator in Toxoplasma gondii. Mol. Microbiol. 2002, 45:321-332.
9. Kurokawa H., Kato K., Iwanaga T., Sugi T., Sudo A., Kobayashi K., Gong H., Takemae H., Recuenco F.C., Horimoto T., Akashi H. Identification of Toxoplasma gondii cAMP dependent protein kinase and its role in the tachyzoite growth. PLoS ONE 2011, 6:e22492.
10. Larson E.T., Ojo K.K., Murphy R.C., Johnson S.M., Zhang Z., Kim J.E., Leibly D.J., Fox A.M., Reid M.C., Dale E.J., Perera B.G., Kim J., Hewitt S.N., Hol W.G., Verlinde C.L., Fan E., Van Voorhis W.C., Maly D.J., Merritt E.A. Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1. J. Med. Chem. 2012, 55:2803-2810.
11. Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., Marth G., Abecasis G., Durbin R., Subgroup G.P.D.P. The sequence alignment/map format and SAMtools. Bioinformatics 2009, 25:2078-2079.
12. Lourido S., Shuman J., Zhang C., Shokat K.M., Hui R., Sibley L.D. Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma. Nature 2010, 465:359-362.
13. Marchler-Bauer A., Lu S., Anderson J.B., Chitsaz F., Derbyshire M.K., DeWeese-Scott C., Fong J.H., Geer L.Y., Geer R.C., Gonzales N.R., Gwadz M., Hurwitz D.I., Jackson J.D., Ke Z., Lanczycki C.J., Lu F., Marchler G.H., Mullokandov M., Omelchenko M.V., Robertson C.L., Song J.S., Thanki N., Yamashita R.A., Zhang D., Zhang N., Zheng C., Bryant S.H. CDD: a conserved domain database for the functional annotation of proteins. Nucleic Acids Res. 2011, 39:D225-229.
14. Miranda-Saavedra D., Gabaldón T., Barton G.J., Langsley G., Doerig C. The kinomes of apicomplexan parasites. Microbes Infect. 2012, 14:796-810.
15. Murphy R.C., Ojo K.K., Larson E.T., Castellanos-Gonzalez A., Perera B.G., Keyloun K.R., Kim J.E., Bhandari J.G., Muller N.R., Verlinde C.L., White A.C., Merritt E.A., Van Voorhis W.C., Maly D.J. Discovery of potent and selective inhibitors of calcium-dependent protein kinase 1 (CDPK1) from C. parvum and T. gondii. ACS Med. Chem. Lett. 2010, 1:331-335.
16. Nagamune K., Moreno S.N., Sibley L.D. Artemisinin-resistant mutants of Toxoplasma gondii have altered calcium homeostasis. Antimicrob. Agents Chemother. 2007, 51:3816-3823.
17. Ojo K., Larson E., Keyloun K., Castaneda L., Derocher A., Inampudi K., Kim J., Arakaki T., Murphy R., Zhang L., Napuli A., Maly D., Verlinde C., Buckner F., Parsons M., Hol W., Merritt E., Van Voorhis W. Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors. Nat. Struct. Mol. Biol. 2010, 17:602-607.
18. Ojo K.K., Pfander C., Mueller N.R., Burstroem C., Larson E.T., Bryan C.M., Fox A.M., Reid M.C., Johnson S.M., Murphy R.C., Kennedy M., Mann H., Leibly D.J., Hewitt S.N., Verlinde C.L., Kappe S., Merritt E.A., Maly D.J., Billker O., Van Voorhis W.C. Transmission of malaria to mosquitoes blocked by bumped kinase inhibitors. J. Clin. Invest. 2012, 122:2301-2305.
19. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 2004, 25:1605-1612.
20. Ray A., Cowan-Jacob S.W., Manley P.W., Mestan J., Griffin J.D. Identification of BCR-ABL point mutations conferring resistance to the Abl kinase inhibitor AMN107 (nilotinib) by a random mutagenesis study. Blood 2007, 109:5011-5015.
21. Roos D.S., Donald R.G.K., Morrissette N.S., Moulton A.L.C. Molecular tools for genetic dissection of the protozoan parasite Toxoplasma gondii. Meth. Cell Biol. 1994, 45:27-63.
22. Shokat K., Velleca M. Novel chemical genetic approaches to the discovery of signal transduction inhibitors. Drug Discov. Today 2002, 7:872-879.
23. Sugi T., Kato K., Kobayashi K., Watanabe S., Kurokawa H., Gong H., Pandey K., Takemae H., Akashi H. Use of the kinase inhibitor analog 1NM-PP1 reveals a role for Toxoplasma gondii CDPK1 in the invasion step. Eukaryot. Cell 2010, 9:667-670.
24. Unno A., Suzuki K., Batanova T., Cha S., Jang H., Kitoh K., Takashima Y. Visualization of Toxoplasma gondii stage conversion by expression of stage-specific dual fluorescent proteins. Parasitology 2009, 136:579-588.
25. Wei S., Marches F., Daniel B., Sonda S., Heidenreich K., Curiel T. Pyridinylimidazole p38 mitogen-activated protein kinase inhibitors block intracellular Toxoplasma gondii replication. Int. J. Parasitol. 2002, 32:969-977.
26. Weisberg E., Griffin J.D. Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL-transformed hematopoietic cell lines. Blood 2000, 95:3498-3505.